Literature DB >> 27686355

Incidence of severe sepsis and septic shock in German intensive care units: the prospective, multicentre INSEP study.

.   

Abstract

PURPOSE: To estimate the incidence density, point prevalence and outcome of severe sepsis and septic shock in German intensive care units (ICUs).
METHODS: In a prospective, multicentre, longitudinal observational study, all patients already on the ICU at 0:00 on 4 November 2013 and all patients admitted to a participating ICU between 0:00 on 4 November 2013 and 2359 hours on 1 December 2013 were included. The patients were followed up for the occurrence of severe sepsis or septic shock (SEPSIS-1 definitions) during their ICU stay.
RESULTS: A total of 11,883 patients from 133 ICUs at 95 German hospitals were included in the study, of whom 1503 (12.6 %) were diagnosed with severe sepsis or septic shock. In 860 cases (57.2 %) the infections were of nosocomial origin. The point prevalence was 17.9 % (95 % CI 16.3-19.7).The calculated incidence rate of severe sepsis or septic shock was 11.64 (95 % CI 10.51-12.86) per 1000 ICU days. ICU mortality in patients with severe sepsis/septic shock was 34.3 %, compared with 6 % in those without sepsis. Total hospital mortality of patients with severe sepsis or septic shock was 40.4 %. Classification of the septic shock patients using the new SEPSIS-3 definitions showed higher ICU and hospital mortality (44.3 and 50.9 %).
CONCLUSIONS: Severe sepsis and septic shock continue to be a frequent syndrome associated with high hospital mortality. Nosocomial infections play a major role in the development of sepsis. This study presents a pragmatic, affordable and feasible method for the surveillance of sepsis epidemiology. Implementation of the new SEPSIS-3 definitions may have a major effect on future epidemiological data.

Entities:  

Keywords:  Incidence; Incidence density; Prevalence; Sepsis; Septic shock

Mesh:

Year:  2016        PMID: 27686355     DOI: 10.1007/s00134-016-4504-3

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN: 0342-4642            Impact factor:   17.440


  26 in total

1.  Long-term cognitive impairment and functional disability among survivors of severe sepsis.

Authors:  Theodore J Iwashyna; E Wesley Ely; Dylan M Smith; Kenneth M Langa
Journal:  JAMA       Date:  2010-10-27       Impact factor: 56.272

2.  Nationwide trends of severe sepsis in the 21st century (2000-2007).

Authors:  Gagan Kumar; Nilay Kumar; Amit Taneja; Thomas Kaleekal; Sergey Tarima; Emily McGinley; Edgar Jimenez; Anand Mohan; Rumi Ahmed Khan; Jeff Whittle; Elizabeth Jacobs; Rahul Nanchal
Journal:  Chest       Date:  2011-08-18       Impact factor: 9.410

3.  Benchmarking the incidence and mortality of severe sepsis in the United States.

Authors:  David F Gaieski; J Matthew Edwards; Michael J Kallan; Brendan G Carr
Journal:  Crit Care Med       Date:  2013-05       Impact factor: 7.598

4.  High versus low blood-pressure target in patients with septic shock.

Authors:  Pierre Asfar; Ferhat Meziani; Jean-François Hamel; Fabien Grelon; Bruno Megarbane; Nadia Anguel; Jean-Paul Mira; Pierre-François Dequin; Soizic Gergaud; Nicolas Weiss; François Legay; Yves Le Tulzo; Marie Conrad; René Robert; Frédéric Gonzalez; Christophe Guitton; Fabienne Tamion; Jean-Marie Tonnelier; Pierre Guezennec; Thierry Van Der Linden; Antoine Vieillard-Baron; Eric Mariotte; Gaël Pradel; Olivier Lesieur; Jean-Damien Ricard; Fabien Hervé; Damien du Cheyron; Claude Guerin; Alain Mercat; Jean-Louis Teboul; Peter Radermacher
Journal:  N Engl J Med       Date:  2014-03-18       Impact factor: 91.245

5.  Epidemiology, microbiology and outcomes of healthcare-associated and community-acquired bacteremia: a multicenter cohort study.

Authors:  Marin H Kollef; Marya D Zilberberg; Andrew F Shorr; Lien Vo; Jeffrey Schein; Scott T Micek; Myoung Kim
Journal:  J Infect       Date:  2010-12-30       Impact factor: 6.072

6.  Nosocomial infections and multidrug-resistant organisms in Germany: epidemiological data from KISS (the Hospital Infection Surveillance System).

Authors:  Christine Geffers; Petra Gastmeier
Journal:  Dtsch Arztebl Int       Date:  2011-02-11       Impact factor: 5.594

7.  Epidemiology of sepsis in Germany: results from a national prospective multicenter study.

Authors:  Christoph Engel; Frank M Brunkhorst; Hans-Georg Bone; Reinhard Brunkhorst; Herwig Gerlach; Stefan Grond; Matthias Gruendling; Guenter Huhle; Ulrich Jaschinski; Stefan John; Konstantin Mayer; Michael Oppert; Derk Olthoff; Michael Quintel; Max Ragaller; Rolf Rossaint; Frank Stuber; Norbert Weiler; Tobias Welte; Holger Bogatsch; Christiane Hartog; Markus Loeffler; Konrad Reinhart
Journal:  Intensive Care Med       Date:  2007-02-24       Impact factor: 17.440

8.  Rapid increase in hospitalization and mortality rates for severe sepsis in the United States: a trend analysis from 1993 to 2003.

Authors:  Viktor Y Dombrovskiy; Andrew A Martin; Jagadeeshan Sunderram; Harold L Paz
Journal:  Crit Care Med       Date:  2007-05       Impact factor: 7.598

9.  How many general and inflammatory variables need to be fulfilled when defining sepsis due to the 2003 SCCM/ESICM/ACCP/ATS/SIS definitions in critically ill surgical patients: a retrospective observational study.

Authors:  Manfred Weiss; Markus Huber-Lang; Michael Taenzer; Martina Kron; Birgit Hay; Maximilian Nass; Moritz Huber; Marion Schneider
Journal:  BMC Anesthesiol       Date:  2010-12-21       Impact factor: 2.217

10.  The epidemiology of severe sepsis in England, Wales and Northern Ireland, 1996 to 2004: secondary analysis of a high quality clinical database, the ICNARC Case Mix Programme Database.

Authors:  David A Harrison; Catherine A Welch; Jane M Eddleston
Journal:  Crit Care       Date:  2006       Impact factor: 9.097

View more
  72 in total

Review 1.  [S2k guidelines of the PEG on calculated parenteral initial treatment of bacterial diseases in adults : Focussed summary and supplementary information on antibiotic treatment of critically ill patients].

Authors:  A Brinkmann; A C Röhr; O R Frey; W A Krüger; T Brenner; D C Richter; K-F Bodmann; M Kresken; B Grabein
Journal:  Anaesthesist       Date:  2018-12       Impact factor: 1.041

2.  [New Sepsis-3 definition : Do we have to treat sepsis before we can diagnose it from now on?]

Authors:  T Schmoch; M Bernhard; F Uhle; M Gründling; T Brenner; M A Weigand
Journal:  Anaesthesist       Date:  2017-08       Impact factor: 1.041

3.  [The qSOFA in the emergency department for early diagnosis of sepsis].

Authors:  M Oppert
Journal:  Med Klin Intensivmed Notfmed       Date:  2017-06-06       Impact factor: 0.840

4.  Hydrocortisone in septic shock: all the questions answered?

Authors:  Josef Briegel; Volker Huge; Patrick Möhnle
Journal:  J Thorac Dis       Date:  2018-06       Impact factor: 2.895

5.  [Intensive care studies from 2017/2018].

Authors:  C J Reuß; M Bernhard; C Beynon; A Hecker; C Jungk; C Nusshag; M A Weigand; D Michalski; T Brenner
Journal:  Anaesthesist       Date:  2018-09       Impact factor: 1.041

6.  Implementation of the Sepsis-3 definition in German university intensive care units : A survey.

Authors:  U Keppler; T Schmoch; B H Siegler; M A Weigand; F Uhle
Journal:  Anaesthesist       Date:  2018-06-26       Impact factor: 1.041

7.  In sepsis, everything old is new again.

Authors:  Anthony Delaney; Flavia Machado
Journal:  Intensive Care Med       Date:  2016-09-29       Impact factor: 17.440

Review 8.  [Adequate anti-infective treatment : Importance of individual dosing and application].

Authors:  A Brinkmann; A C Röhr; A Köberer; T Fuchs; W A Krüger; C König; D Richter; M A Weigand; O R Frey
Journal:  Anaesthesist       Date:  2018-06       Impact factor: 1.041

Review 9.  Sepsis: frontiers in supportive care, organisation and research.

Authors:  Anders Perner; Andrew Rhodes; Bala Venkatesh; Derek C Angus; Ignacio Martin-Loeches; Jean-Charles Preiser; Jean-Louis Vincent; John Marshall; Konrad Reinhart; Michael Joannidis; Steven M Opal
Journal:  Intensive Care Med       Date:  2017-01-27       Impact factor: 17.440

Review 10.  [Intensive care aspects of autoimmune encephalitis].

Authors:  A Günther; J Schubert; O W Witte; D Brämer
Journal:  Med Klin Intensivmed Notfmed       Date:  2019-08-27       Impact factor: 0.840

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.